- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.41 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 6 x XC9: 1-[6-[azanylidene-[[azanylidene-[[(4-chlorophenyl)amino]methyl]-$l^{4}-azanyl]methyl]-$l^{4}-azanyl]hexyl]-3-[~{N}-(4-chlorophenyl)carbamimidoyl]guanidine(Non-covalent)
XC9.2: 10 residues within 4Å:- Chain A: F.44, D.46, A.53, W.56, R.57, L.83, M.85, S.103, F.104, F.422
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:A.53, A:W.56, A:W.56, A:L.83, A:F.104
- Hydrogen bonds: A:D.46, A:S.103, A:F.422
- Salt bridges: A:D.46, A:D.46
- pi-Cation interactions: A:W.56
XC9.4: 10 residues within 4Å:- Chain B: F.44, D.46, A.53, W.56, R.57, L.83, M.85, S.103, F.104, F.422
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:A.53, B:W.56, B:W.56, B:L.83, B:F.104
- Hydrogen bonds: B:D.46, B:S.103, B:F.422
- Salt bridges: B:D.46, B:D.46
- pi-Cation interactions: B:W.56
XC9.6: 10 residues within 4Å:- Chain C: F.44, D.46, A.53, W.56, R.57, L.83, M.85, S.103, F.104, F.422
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:A.53, C:W.56, C:W.56, C:L.83, C:F.104
- Hydrogen bonds: C:D.46, C:S.103, C:F.422
- Salt bridges: C:D.46, C:D.46
- pi-Cation interactions: C:W.56
XC9.8: 10 residues within 4Å:- Chain D: F.44, D.46, A.53, W.56, R.57, L.83, M.85, S.103, F.104, F.422
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:A.53, D:W.56, D:W.56, D:L.83, D:F.104
- Hydrogen bonds: D:D.46, D:S.103, D:F.422, D:F.422
- Salt bridges: D:D.46, D:D.46
- pi-Cation interactions: D:W.56
XC9.10: 10 residues within 4Å:- Chain E: F.44, D.46, A.53, W.56, R.57, L.83, M.85, S.103, F.104, F.422
12 PLIP interactions:12 interactions with chain E- Hydrophobic interactions: E:A.53, E:W.56, E:W.56, E:L.83, E:F.104
- Hydrogen bonds: E:D.46, E:S.103, E:F.422, E:F.422
- Salt bridges: E:D.46, E:D.46
- pi-Cation interactions: E:W.56
XC9.12: 10 residues within 4Å:- Chain F: F.44, D.46, A.53, W.56, R.57, L.83, M.85, S.103, F.104, F.422
12 PLIP interactions:12 interactions with chain F- Hydrophobic interactions: F:A.53, F:W.56, F:W.56, F:L.83, F:F.104
- Hydrogen bonds: F:D.46, F:S.103, F:F.422, F:F.422
- Salt bridges: F:D.46, F:D.46
- pi-Cation interactions: F:W.56
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pang, A.H. et al., Discovery and Mechanistic Analysis of Structurally Diverse Inhibitors of Acetyltransferase Eis among FDA-Approved Drugs. Biochemistry (2023)
- Release Date
- 2023-02-08
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.41 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 6 x XC9: 1-[6-[azanylidene-[[azanylidene-[[(4-chlorophenyl)amino]methyl]-$l^{4}-azanyl]methyl]-$l^{4}-azanyl]hexyl]-3-[~{N}-(4-chlorophenyl)carbamimidoyl]guanidine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pang, A.H. et al., Discovery and Mechanistic Analysis of Structurally Diverse Inhibitors of Acetyltransferase Eis among FDA-Approved Drugs. Biochemistry (2023)
- Release Date
- 2023-02-08
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A